Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Drug Safety|April 13, 2013
Pharmacovigilance systems in developing countries: an evaluative case study in Burkina FasoLassane Kabore, Pascal Millet, Souleymane Fofana, et al.Therapeutic Innovation & Regulatory Science|September 18, 2018
Actions of the National Regulatory Authorities in 10 Low- and Middle-Income Countries Following Stringent Regulatory Authority Safety Alerts on RosiglitazoneJude Nwokike, Lassane Kabore, Andy StergachisTherapie|May 19, 2018
[Psychoactive substances use in Réunion Island and Mayotte, French departments in Indian Ocean]Amélie Daveluy, Françoise HaramburuTherapie|June 26, 2003
[Some questions about statins]Jacques Dangoumau, Françoise Haramburu, Bernard BégaudTherapie|July 10, 2016
Which Pharmacovigilance for Vaccines?Hervé Le Louët, Elisabeth Loupi, Françoise Haramburu, et al.Therapie|September 7, 2007
Which pharmacovigilance for vaccines?Hervé Le Louët, Elisabeth Loupi, Françoise Haramburu, et al.Medecine Tropicale Et Sante Internationale|June 10, 2022
[Chronicle of a death foretold: the fateful fate of french tropical medicine disciplines and its consequences in the fight against health inequalities in Africa]Pascal MilletJournal of the International Association of Providers of AIDS Care|November 26, 2014
Self-Report Measures in the Assessment of Antiretroviral Medication Adherence: Comparison with Medication Possession Ratio and HIV Viral LoadLassane Kabore, Paul Muntner, Eric Chamot, et al.Pageof 14